Taiwan
# |
Name |
Debt to Equity Ratio |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
1.42
|
Dec. 31, 2023 | USD 2.07 | NA |
|
Taiwan |
|
2 |
0.81
|
Dec. 31, 2023 | USD 1.34 | NA |
|
Taiwan |
|
3 |
0.67
|
Dec. 31, 2023 | USD 7.84 | NA |
|
Taiwan |
|
4 |
0.54
|
Dec. 31, 2023 | USD 2.22 | NA |
|
Taiwan |
|
5 |
0.51
|
Dec. 31, 2023 | USD 1.58 | NA |
|
Taiwan |
|
6 |
0.38
|
Dec. 31, 2023 | USD 2.64 | NA |
|
Taiwan |
|
7 |
0.29
|
Dec. 31, 2023 | USD 2.60 | NA |
|
Taiwan |
|
8 |
0.28
|
Dec. 31, 2023 | USD 1.24 | NA |
|
Taiwan |
|
9 |
0.28
|
Dec. 31, 2023 | USD 3.66 | NA |
|
Taiwan |
|
10 |
0.25
|
Dec. 31, 2023 | USD 1.26 | NA |
|
Taiwan |
|
11 |
0.25
|
Dec. 31, 2023 | USD 1.87 | NA |
|
Taiwan |
|
12 |
0.22
|
Dec. 31, 2023 | USD 0.69 | NA |
|
Taiwan |
|
13 |
0.17
|
Dec. 31, 2023 | USD 2.59 | NA |
|
Taiwan |
|
14 |
0.13
|
Dec. 31, 2023 | USD 1.81 | NA |
|
Taiwan |
|
15 |
0.08
|
Dec. 31, 2023 | USD 0.62 | NA |
|
Taiwan |
|
16 |
0.07
|
Dec. 31, 2023 | USD 0.34 | NA |
|
Taiwan |
|
17 |
0.06
|
Dec. 31, 2023 | USD 0.68 | NA |
|
Taiwan |
|
18 |
0.05
|
Dec. 31, 2023 | USD 0.97 | NA |
|
Taiwan |
|
19 |
0.04
|
Dec. 31, 2023 | USD 0.61 | NA |
|
Taiwan |
|
20 |
0.03
|
Dec. 31, 2023 | USD 2.34 | NA |
|
Taiwan |
|
21 |
0.01
|
Dec. 31, 2023 | USD 0.49 | NA |
|
Taiwan |
|
22 |
0.01
|
Dec. 31, 2023 | USD 0.95 | NA |
|
Taiwan |
|
23 |
0.00
|
Dec. 31, 2023 | USD 3.03 | NA |
|
Taiwan |
The Biotechnology company in Taiwan with the highest Debt to Equity Ratio is Bionime Corporation (Taiwan Stock Exchange: 4737.TW) at 1.42.
The Biotechnology company in Taiwan with the lowest Debt to Equity Ratio is PharmaEngine, Inc. (Taipei Exchange: 4162.TWO) at 0.00.
The top 10 Biotechnology companies in Taiwan by Debt to Equity Ratio are Bionime Corporation, CHC Healthcare Group, Lotus Pharmaceutical Co., Ltd., Formosa Laboratories, Inc., Medigen Vaccine Biologics Corporation, Panion & Bf Biotech Inc., TaiMed Biologics Inc., Center Laboratories, Inc., Bioteque Corporation and Nang Kuang Pharmaceutical Co., Ltd..
The bottom 10 Biotechnology companies in Taiwan by Debt to Equity Ratio are PharmaEngine, Inc., Abnova (Taiwan) Corporation, PhytoHealth Corporation, Oneness Biotech Co., Ltd., GenMont Biotech Incorporation, Microbio Co., Ltd., ScinoPharm Taiwan, Ltd., TaiGen Biopharmaceuticals Holdings Limited, Savior Lifetec Corporation and OBI Pharma, Inc..